Methamphetamine psychosis, the efficacy of atypical antipsychotics

Worldwide growing methamphetamine abuse is one of the most serious health problems with several different consequences for victims, especially in developing countries. Chronic methamphetamine abuse is associated with several psychiatric problems in all countries which are faced to epidemic methamphe...

Full description

Bibliographic Details
Main Authors: Amir Rezaei Ardani, Azam Motamedi Nasab
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2014-12-01
Series:Reviews in Clinical Medicine
Subjects:
Online Access:http://rcm.mums.ac.ir/pdf_3375_13aeb567fe2aeb4498f1f0e36a85a56e.html
Description
Summary:Worldwide growing methamphetamine abuse is one of the most serious health problems with several different consequences for victims, especially in developing countries. Chronic methamphetamine abuse is associated with several psychiatric problems in all countries which are faced to epidemic methamphetamine abuse. Methamphetamine-induced psychosis is a major medical challenge for clinical practitioner from both diagnostic and therapeutic viewpoints. Stimulant psychosis commonly occurs in people who abuse stimulants, but it also occurs in some patients taking therapeutic doses of stimulant drugs under medical supervision. The main characteristic of meth psychosis is the presence of prominent hallucinations and delusions. Other drugs, such as cocaine and marijuana, can trigger the onset of psychosis in someone who is already at increased risk because they have “vulnerability”.The current literature review attends to explain several aspects of MIP epidemiologically and clinically. Investigators proposed pharmacologically treatment based on recently published data.
ISSN:2345-6256
2345-6892